Dr. Lain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5145 FM 620 N
Ste B-110
Austin, TX 78732Phone+1 512-266-0007Fax+1 512-266-0077
Summary
- Dr. Edward Lain is a dermatologist in Austin, TX. He received his medical degree from Baylor College of Medicine and has been in practice 15 years. He specializes in acne & rosacea, cosmetic dermatology, dermatologic surgery, and pediatric dermatology and is experienced in dermatologic surgery, cosmetic dermatology, pediatric dermatology, mohs micrographic surgery, and laser resurfacing/fractional laser resurfacing.
Education & Training
- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Dermatology, 2003 - 2006
- University of Arkansas for Medical Sciences (UAMS) College of MedicineInternship, Internal Medicine, 2002 - 2003
- Rice University Jesse H Jones Graduate School of ManagementMBA, Healthcare Administration, 2000 - 2002
- Baylor College of MedicineClass of 2002
Certifications & Licensure
- TX State Medical License 2005 - 2024
- AR State Medical License 2004 - 2007
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- VPD-737 for Treatment of Chronic Pruritus Start of enrollment: 2013 Oct 15
- A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris Start of enrollment: 2014 Aug 01
- A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Start of enrollment: 2015 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 26 citationsEfficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials.Boni E. Elewski, Phoebe Rich, Edward Lain, Jennifer Soung, George Michael Lewitt
The Journal of Dermatological Treatment. 2020-04-21 - 10 citationsRoflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.Andrew Blauvelt, Zoe D Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia
Journal of the American Academy of Dermatology. 2024-05-01 - 5 citationsOnce-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.Leon H Kircik, Javier Alonso-Llamazares, Neal Bhatia, Michael Bukhalo, Alim R Devani
The British Journal of Dermatology. 2023-09-15
Press Mentions
- Athenex Announces Positive Topline Results from Two Phase III Studies of KX2-391 Ointment 1% Featured in Late Breaker Program at the 2019 American Academy of Dermatology Annual MeetingMarch 4th, 2019
- Galderma Announces Positive Results from the “CoMMPlete” Regimen Study Including Epiduo® Gel in the Management of Acne in Adolescent Student AthletesMay 24th, 2016
Professional Memberships
- Fellow
- Member
- Member
- Fellow
External Links
- Dr Ted Lain Dermatologyhttp://www.atxderm.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: